Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1832526 (
PCC
)
5,967
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The genes opcA and zwf are located close to each other in most of cyanobacterial strains and the mutations in the opcA gene were reported to lose most of
G6PDH
activity. One of the reasons suggested for this loss was the polar effect of the mutation on expression of the zwf gene in the same operon and the other was absence of the OpcA polypeptide necessary for the catalytic activity of
G6PDH
. Synechocystis sp.
PCC
6803 exhibits a gene organisation in which opcA and zwf are far away from each other and is ideal for analysis of an opcA mutation alone. In this study, an opcA single mutant and an opcA-zwf double mutant were constructed and effects of the opcA mutation on
G6PDH
activity and dark viability were then investigated. Contrary to the previous observations, no negative effect of the mutation on
G6PDH
activity was found under the optimal substrate concentrations. However, when one of the substrates, G6P or NADP, was reduced gradually,
G6PDH
activity in the mutant cells decreased faster than the wild types. Our results indicated that an opcA mutation did not affect
G6PDH
activity severely when zwf and opcA were in different operons. Similarly, dark viability of the opcA single and the zwf-opcA double mutants did not exhibit meaningful difference from the wild type.
...
PMID:Characterisation of an opcA Mutant of the Unicellular Cyanobacterium Synechocystis sp. PCC 6803. 2625 65